This project involved direction of an intense focused ultrasound beam at the region of the ciliary body to cause cyclodestruction. This project eventually led to a commercial device (Sonocare, Inc.) manufactured under license by Cornell, and a multicenter clinical trial.
The project involved guiding an intense focused sound wave at the ciliary body region to create cyclodestruction. The project eventually resulted in a commercially available device (Sonocare, Inc.) developed under license from Cornell, followed by a multicenter clinical trial.